Together with the fact that Sirt3 interacts with and deacetylates LONP1, Sirt3 may limit the transformation procedure in cancer initiation by maintaining appropriate lysosomal degradation of LONP1 through K63-ubiquitination pathway. The gene discussed is SIRT3; the disease is cancer.